Insight Molecular Diagnostics Ratios (2020-2025) | IMDX

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin -9,212.50%-110.49%-8.29%-42.35%7.03%-19.41%-88.01%72.47%-37.43%13.08%-401.49%-9.85%3.37%58.75%57.81%-37.26%25.57%48.08%43.48%40.04%61.97%67.57%53.46%
EBT Margin -55,168.75%-6,369.23%-1,222.16%-1,285.88%-1,021.62%-605.27%-1,402.44%-997.16%-722.68%-575.53%-2,713.43%-4,385.77%2,006.40%-1,799.78%-1,512.59%-5,152.55%-5,186.93%-4,453.85%-11,752.17%-2,262.92%-318.01%-1,900.00%-4,249.23%
EBIT Margin -52,693.75%-6,131.47%-1,125.05%-1,245.92%-1,010.68%-668.37%-1,382.52%-994.15%-694.87%-686.08%-2,546.27%-4,251.09%1,969.70%-1,791.36%-1,518.18%-5,152.55%-5,265.34%-4,453.85%-11,752.17%-2,262.92%-318.01%-1,900.00%-4,249.23%
EBITDA Margin -52,693.75%-6,131.47%-1,125.05%-1,245.92%-1,010.68%-668.37%-1,382.52%-994.15%-694.87%-686.08%-2,546.27%-4,251.09%1,969.70%-1,791.36%-1,518.18%-5,152.55%-5,265.34%-4,453.85%-11,752.17%-2,262.92%-318.01%-1,900.00%-4,249.23%
Operating Margin -52,693.75%-6,131.47%-1,125.05%-1,245.92%-1,010.68%-668.37%-1,382.52%-994.15%-694.87%-686.08%-2,546.27%-4,251.09%1,969.70%-1,791.36%-1,518.18%-5,152.55%-5,265.34%-4,453.85%-11,752.17%-2,262.92%-318.01%-1,900.00%-4,249.23%
Net Margin -62,012.50%-4,837.76%-1,222.16%-1,317.50%-348.67%-693.65%-1,402.44%-999.86%-722.68%-4,342.19%-14,368.66%-16,497.81%1.65%-1,866.95%-1,558.74%-5,152.55%-5,303.98%-4,410.58%-11,733.04%-2,262.92%-312.02%-1,880.69%-4,174.62%
FCF Margin -43,212.50%-5,211.19%-1,176.76%-1,254.47%-949.91%-428.62%-1,152.85%-208.02%-1,041.99%-5,217.30%-18,291.04%-3,813.87%-2,794.61%-1,475.59%-747.09%-1,492.99%-2,189.77%-5,931.73%-4,884.35%-376.11%-288.35%-1,279.54%-2,135.38%
Efficiency
Inventory Average 0.32M0.43M0.58M0.58M
Assets Average 61.48M60.62M56.60M92.36M153.34M172.86M163.95M152.92M128.72M84.56M78.24M72.93M72.85M72.47M52.65M47.72M55.44M47.23M
Equity Average 38.11M37.12M34.06M70.06M104.65M101.01M82.28M61.09M55.57M40.58M29.02M16.03M17.15M16.21M-1.28M-1.03M5.66M-4.05M
Invested Capital 38.12M41.08M36.70M35.87M109.22M114.40M101.58M66.61M57.91M76.97M34.40M43.71M37.67M22.78M11.59M22.70M10.32M-12.05M10.65M1.79M-8.14M
Asset Utilization Ratio 0.020.030.030.030.050.050.020.020.020.020.010.010.040.080.080.09
Leverage & Solvency
Debt to Equity 0.080.100.120.120.030.120.020.020.020.000.000.000.000.110.06-0.020.040.63-0.11
Debt Ratio 0.050.060.070.070.030.070.010.010.010.000.000.000.000.030.010.010.010.010.02
Equity Ratio 0.620.620.600.600.820.580.590.410.390.490.340.500.460.270.160.300.14-0.350.170.02-0.21
Valuation
Enterprise Value 134.45M111.25M82.83M152.91M401.67M468.00M281.77M166.29M116.44M106.63M54.07M20.67M42.05M19.98M11.47M13.32M18.60M30.13M34.70M31.43M56.48M62.07M75.59M
Market Capitalization 153.05M128.39M93.48M160.73M461.46M515.60M326.03M200.14M137.45M106.63M86.58M41.09M42.05M37.91M25.71M22.75M24.20M39.43M38.10M40.07M87.51M86.37M95.02M
Return Ratios
Return on Sales -24.86%-10.43%-7.46%-8.28%-8.73%-9.20%-10.69%-11.36%-28.79%-57.46%-46.99%-34.66%-22.57%-29.04%-35.61%-61.29%-32.38%-15.24%-14.98%-13.93%
Return on Capital Employed -0.62%-0.39%-0.28%-0.28%-0.50%-0.52%-0.21%-0.27%-0.35%-0.62%-0.56%-0.69%-1.35%-1.54%-1.31%-1.55%
Return on Invested Capital -0.34%-0.26%-0.81%
Return on Assets -0.53%-0.26%-0.20%-0.22%-0.41%-0.48%-0.45%-0.60%-0.43%-0.55%-0.50%-0.60%-1.16%-1.23%-1.15%-1.30%
Return on Equity -0.89%-0.35%-0.30%-0.38%-0.82%-1.21%-1.04%-1.25%-1.17%-2.50%-2.12%-2.68%47.52%56.98%-11.27%15.14%